Skip to main content
. 2016 Nov 11;9:6977–6985. doi: 10.2147/OTT.S117161

Figure 6.

Figure 6

The pooled OR from four studies with 259 NSCLC samples showing the association of p14ARF promoter methylation with clinicopathological characteristics, including tumor stage, tumor histology, gender status, tumor differentiation, smoking status, and lymph node status (all P>0.05).

Abbreviations: AC, adenocarcinoma; CI, confidence interval; NSCLC, non-small-cell lung cancer; OR, odds ratio; SCC, squamous cell carcinoma; NA, not applicable.